Novavax signs licensing agreement with Pfizer for vaccine development

Go back to Novavax signs licensing agreement with Pfizer for vaccine development
Novavax, Inc. (NASDAQ: NVAX) Delayed: 7.89 -0.06 (0.75%)
Previous Close $7.95    52 Week High $9.23 
Open $7.89    52 Week Low $1.16 
Day High $7.96    P/E N/A 
Day Low $7.70    EPS $-0.30 
Volume 3,218,611